• EI
  • Scopus
  • 中国科技期刊卓越行动计划项目资助期刊
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国精品科技期刊
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国科技核心期刊CSTPCD
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
徐蓉蓉, 高垚垚, 周云龙, 胡荣. 薏苡仁油β-环糊精包合物的制备及其表征[J]. 食品工业科技, 2017, (12): 258-263. DOI: 10.13386/j.issn1002-0306.2017.12.047
引用本文: 徐蓉蓉, 高垚垚, 周云龙, 胡荣. 薏苡仁油β-环糊精包合物的制备及其表征[J]. 食品工业科技, 2017, (12): 258-263. DOI: 10.13386/j.issn1002-0306.2017.12.047
XU Rong-rong, GAO Yao-yao, ZHOU Yun-long, HU Rong. Preparation and characterization of Adlay seed oil and β-cyclodextrin inclusion complexes[J]. Science and Technology of Food Industry, 2017, (12): 258-263. DOI: 10.13386/j.issn1002-0306.2017.12.047
Citation: XU Rong-rong, GAO Yao-yao, ZHOU Yun-long, HU Rong. Preparation and characterization of Adlay seed oil and β-cyclodextrin inclusion complexes[J]. Science and Technology of Food Industry, 2017, (12): 258-263. DOI: 10.13386/j.issn1002-0306.2017.12.047

薏苡仁油β-环糊精包合物的制备及其表征

Preparation and characterization of Adlay seed oil and β-cyclodextrin inclusion complexes

  • 摘要: 采用饱和水溶液法制备薏苡仁油β-环糊精(β-CD)包合物;Box-Behnken响应面法优化并验证制备条件为:包合投料质量比(β-CD∶薏苡仁)为9∶1,包合温度45℃,包合时间6 h。通过SEM、DSC、FTIR、XRD表征薏苡仁油β-CD包合物的形成;HPLC法测定β-CD对薏苡仁油包合率达63%;包合物溶液以最大浓度(63 mg/m L)、最大给药量(0.04 m L/g)小鼠灌胃14 d后,心、肝、脾、肺、肾整体观察和各脏器切片均无明显病理变化,提示制备的薏苡仁油β-CD包合物食用安全,可进一步进行功效研究。 

     

    Abstract: To prepare the β-cyclodextrin inclusion of Adlay seed oil with a saturated aqueous solution.The optimum by BoxBehnken response surface design were as follows-the ratio of β-CD to Adlay seed oil 9 ∶ 1 (g/g) , stirring temperature 45 ℃, inclusion time 6 h. The inclusion was characterized by SEM, DSC, FTIR and XRD. Entrapment efficiency of the inclusion determined by HPLC was 63%.In the acute toxicity test, the mice which were fed with the highest concentration (63 mg/m L) and maximum dosage (0.04 m L/g) , no death was found in the experimental mice after 14 days. No organ abnormalities were found and no organ pathology in sliced observation.The prepared inclusion complexes were safety for oral administration to be better for further study of efficacy.

     

/

返回文章
返回